| 000 | 00965 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517153026.0 | ||
| 264 | 0 | _c20180718 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1471-4973 | ||
| 024 | 7 |
_a10.1016/j.coph.2017.04.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuiraud, Simon | |
| 245 | 0 | 0 |
_aPharmacological advances for treatment in Duchenne muscular dystrophy. _h[electronic resource] |
| 260 |
_bCurrent opinion in pharmacology _c06 2017 |
||
| 300 |
_a36-48 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDystrophin _xdeficiency |
| 650 | 0 | 4 |
_aDystrophin-Associated Protein Complex _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMuscular Dystrophy, Duchenne _xdrug therapy |
| 700 | 1 | _aDavies, Kay E | |
| 773 | 0 |
_tCurrent opinion in pharmacology _gvol. 34 _gp. 36-48 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.coph.2017.04.002 _zAvailable from publisher's website |
| 999 |
_c27155711 _d27155711 |
||